Cutera (CUTR) Issues FY18 Earnings Guidance

Cutera (NASDAQ:CUTR) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided EPS guidance of $1.03-1.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.00. The company issued revenue guidance of $178-181 million, compared to the consensus revenue estimate of $166.90 million.

Shares of Cutera (CUTR) traded up $0.70 during midday trading on Wednesday, reaching $46.65. The company’s stock had a trading volume of 170,790 shares, compared to its average volume of 173,909. The firm has a market cap of $638.71, a price-to-earnings ratio of 58.91, a PEG ratio of 1.37 and a beta of 0.41. Cutera has a 12-month low of $18.50 and a 12-month high of $52.90.

Several brokerages have recently commented on CUTR. Maxim Group reiterated a hold rating on shares of Cutera in a research report on Wednesday, November 8th. Zacks Investment Research lowered Cutera from a hold rating to a sell rating in a research report on Tuesday, December 26th. Finally, BidaskClub upgraded Cutera from a hold rating to a buy rating in a research report on Tuesday, December 12th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of Buy and an average price target of $37.33.

In related news, EVP Miguel Pardos sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 12th. The stock was sold at an average price of $46.70, for a total value of $467,000.00. Following the sale, the executive vice president now owns 39,698 shares of the company’s stock, valued at approximately $1,853,896.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director David B. Apfelberg sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $42.55, for a total value of $42,550.00. Following the completion of the sale, the director now directly owns 8,055 shares in the company, valued at approximately $342,740.25. The disclosure for this sale can be found here. In the last quarter, insiders sold 25,018 shares of company stock valued at $1,147,316. Insiders own 3.30% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Cutera (CUTR) Issues FY18 Earnings Guidance” was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.americanbankingnews.com/2018/02/14/cutera-cutr-issues-fy18-earnings-guidance.html.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply